Clinical Trials Browser

INDUSTRY × Interventional × Disease Progression × Clear all

Colonic Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT06635447 2026-01-13

CAPItrue

Phase 3 Recruiting

300 enrolled

Breast

Breast Neoplasms, Disease Progression

NCT04987203 2025-08-22

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Phase 3 Active not recruiting

343 enrolled

Genitourinary

Carcinoma, Renal Cell, Disease Progression

NCT05712356 2025-06-06

BOLSTER

Phase 2 Active not recruiting

67 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT02766699 2025-06-03

CerebralEDV

Phase 1 Completed

9 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Site, Recurrence, Disease Progression

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

122 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

NCT04436120 2024-12-03

TRANSLATE

Phase NA Terminated

38 enrolled 17 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Disease Progression

NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Phase 1 Completed

16 enrolled

Plasma cell

Disease, Multiple Myeloma, Recurrence, Disease Progression

NCT02586987 2019-11-18

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

Phase 1 Completed

58 enrolled

BreastDermatologicGastrointestinalThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms, Disease Progression

NCT01358071 2018-09-27

NGR018

Phase 2 Completed

119 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Phase 4 Unknown

22 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral, Disease Progression

NCT01110668 2017-02-28

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

2 enrolled

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors

NCT00908232 2015-01-15

SEQUENTIAL

Phase 2 Completed

163 enrolled 11 charts

Plasma cell

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT01692262 2014-06-19

PYRUS

Phase 1 Completed

59 enrolled

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Phase 3 Terminated

143 enrolled 10 charts

Plasma cell

Multiple Myeloma, Disease Progression

Clinical Trials

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

CAPItrue

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

BOLSTER

CerebralEDV

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

TRANSLATE

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

NGR018

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

SEQUENTIAL

PYRUS

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I